N. Kerrouche

发表

A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up.

R. Dummer, S. Ibbotson, D. Murrell, 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active‐controlled study and in vitro assays

M. Ghannoum, N. Kerrouche, B. Sigurgeirsson, 2016, Mycoses.

Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years

B. Sigurgeirsson, J. Ólafsson, N. Kerrouche, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase III study throughout Europe

B. Dréno, N. Basset-Seguin, V. von Felbert, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Multicentre intraindividual randomized trial of topical methyl aminolaevulinate–photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities

N. Kerrouche, H. Villemagne, R. Kaufmann, 2008, The British journal of dermatology.

Defining treatment success in rosacea as ‘clear’ may provide multiple patient benefits: results of a pooled analysis

M. Schaller, Jerry Tan, N. Kerrouche, 2017, The Journal of dermatological treatment.

Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.

M. Gooderham, K. Papp, C. Lynde, 2017, Journal of drugs in dermatology : JDD.

Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study

M. Schaller, D. Sarwer, A. Bewley, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)

J. Leyden, Jerry Tan, N. Kerrouche, 2016, Journal of cutaneous medicine and surgery.

Prolonging Time to Flare in Pediatric Atopic Dermatitis: A Randomized, Investigator-Blinded, Controlled, Multicenter Clinical Study of a Ceramide-Containing Moisturizer

Jian-ping Tang, N. Kerrouche, Lin Ma, 2017, Advances in Therapy.

A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40 mg modified-release capsules versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.

M. Schaller, M. Gooderham, L. Kemény, 2020, Journal of the American Academy of Dermatology.

Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis

A. Bewley, J. Fowler, N. Kerrouche, 2016, Dermatology and Therapy.

Prevalence of rosacea in the general population of Germany and Russia – The RISE study

N. Kerrouche, E. Araviiskaia, H. Schöfer, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions.

S. Feldman, Y. Poulin, Jerry Tan, 2011, Journal of the American Academy of Dermatology.

A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0·01%, hydroquinone 4%, tretinoin 0·05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma

N. Kerrouche, K. Park, R. Chan, 2008, The British journal of dermatology.

Cost‐effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan‐European analysis

K. Papp, Y. Poulin, N. Kerrouche, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

A multicentre, randomized, controlled study of the efficacy, safety and cost‐effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement

N. Kerrouche, M. Lecha, R. Kaufmann, 2007, The British journal of dermatology.

Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study

J. Ortonne, A. Nikkels, K. Reich, 2011, The British journal of dermatology.

Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison

B. Dréno, R. Bissonnette, Jerry Tan, 2018, American Journal of Clinical Dermatology.

Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis

K. Papp, R. Bissonnette, Y. Poulin, 2010, The Journal of dermatological treatment.

Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.

K. Papp, R. Bissonnette, Y. Poulin, 2010, Cutis.

Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor

S. Bielfeldt, E. Simpson, N. Kerrouche, 2013, The Journal of dermatological treatment.

Long-Term Effectiveness and Safety of Up to 48 Weeks’ Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne

B. Dréno, R. Bissonnette, Jerry Tan, 2019, American Journal of Clinical Dermatology.

High Patient Satisfaction of a Hyaluronic Acid Filler Producing Enduring Full-Facial Volume Restoration: An 18-Month Open Multicenter Study

N. Kerrouche, S. Talarico, F. Sidou, 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Correction of tear troughs and periorbital lines with a range of customized hyaluronic acid fillers.

B. Rzany, H. Cartier, G. Sattler, 2012, Journal of drugs in dermatology : JDD.

Full‐Face Rejuvenation Using a Range of Hyaluronic Acid Fillers: Efficacy, Safety, and Patient Satisfaction over 6 Months

B. Rzany, H. Cartier, G. Sattler, 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Hyaluronic Acid Filler Injections Under the Metatarsal Heads Provide a Significant and Long-Lasting Improvement in Metatarsalgia From Wearing High-Heeled Shoes

N. Kerrouche, Helen Simpson, Jean Paul Foumenteze, 2018, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis.

Jerry Tan, N. Kerrouche, H. Villemagne, 2009, Cutis.

Intraindividual, right–left comparison of topical methyl aminolaevulinate‐photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study

Cynthia C. Morton, J. Lear, C. Morton, 2006, The British journal of dermatology.

Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial

S. Shumack, H. Wulf, D. Murrell, 2014, The British journal of dermatology.

Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries

S. Ibbotson, C. Cantisani, N. Kerrouche, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler

N. Kerrouche, R. Jain, R. Ruiz-Rodríguez, 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi‐centre European observational study

W. Prager, N. Kerrouche, N. Ribé, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

A subgroup analysis to evaluate the efficacy and safety of adapalene-benzoyl peroxide topical gel in black subjects with moderate acne.

N. Kerrouche, A. Alexis, Lori A. Johnson, 2014, Journal of drugs in dermatology : JDD.

Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.

Sewon Kang, S. Arsonnaud, D. Thiboutot, 2006, Archives of dermatology.

Methyl aminolevulinate daylight photodynamic therapy applied at home for non‐hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany

S. Karrer, R. Aschoff, G. Gauglitz, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris.

J. Schlessinger, R. Brodell, Jerry Tan, 2012, Journal of drugs in dermatology : JDD.

Perioral rejuvenation with a range of customized hyaluronic acid fillers: efficacy and safety over six months with a specific focus on the lips.

B. Rzany, H. Cartier, G. Sattler, 2012, Journal of drugs in dermatology : JDD.

High Patient Satisfaction with Daylight-Activated Methyl Aminolevulinate Cream in the Treatment of Multiple Actinic Keratoses: Results of an Observational Study in Australia

N. Kerrouche, K. Gebauer, J. Sullivan, 2017, Dermatology and Therapy.

Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline.

N. Kerrouche, S. George, D. Roseeuw, 2007, EJD. European journal of dermatology.

A 6‐month maintenance therapy with adapalene‐benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial

J. Fowler, Y. Poulin, N. Kerrouche, 2011, The British journal of dermatology.

Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.

S. Arsonnaud, N. Kerrouche, J. Wolf, 2006, Cutis.

Adapalene-benzoyl Peroxide Gel is Efficacious and Safe in Adult Female Acne, with a Profile Comparable to that Seen in Teen-aged Females.

B. Dréno, N. Kerrouche, H. Baldwin, 2016, The Journal of clinical and aesthetic dermatology.

Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight-photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in 6 European countries

S. Ibbotson, C. Cantisani, N. Kerrouche, 2018 .

The safety and efficacy of four different fixed combination regimens of adapalene 0.1%/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study

R. Bissonnette, Jerry Tan, N. Kerrouche, 2018, European Journal of Dermatology.

Use of Supplementary Patient Education Material Increases Treatment Adherence and Satisfaction Among Acne Patients Receiving Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in Primary Care Clinics: A Multicenter, Randomized, Controlled Clinical Study

S. Royal, N. Kerrouche, T. McCormack, 2017, Dermatology and Therapy.

A treatment for severe nodular acne: a randomized investigator‐blinded, controlled, noninferiority trial comparing fixed‐dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

M. Gooderham, Jerry Tan, C. Lynde, 2014, The British journal of dermatology.

Combination therapy with adapalene–benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double‐blind controlled study

B. Dréno, V. Bettoli, N. Kerrouche, 2011, The British journal of dermatology.

Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.

C. Lynde, N. Kerrouche, T. Dirschka, 2010, Journal of drugs in dermatology : JDD.

Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.

Jerry Tan, N. Kerrouche, J. Jorizzo, 2010, Cutis.

Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.

N. Kerrouche, D. Caron, V. Sorba, 1997, Journal of American Academy of Dermatology.

A fixed-dose combination of adapalene 0.1%–BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne

R. Brodell, A. Wertheimer, S. Tyring, 2012, Journal of dermatological treatment (Print).

Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study

N. Kerrouche, R. Chavda, A. Alexis, 2019, Journal of drugs in dermatology : JDD.

Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars

Sewon Kang, N. Kerrouche, A. Chien, 2018, Dermatology and Therapy.

Adjunctive usage of a non-comedogenic moisturizer with adapalene gel 0.1% improves local tolerance: a randomized, investigator-blinded, split-face study in healthy Asian subjects

N. Kerrouche, K. Matsunaga, Y. Leow, 2013, The Journal of dermatological treatment.

Adjunctive use of a facial moisturizer SPF 30 containing ceramide precursor improves tolerability of topical tretinoin 0.05%: a randomized, investigator-blinded, split-face study.

N. Kerrouche, F. Sidou, Ethlynn S Schorr, 2012, Journal of drugs in dermatology : JDD.

Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability

Mi-ran Kim, N. Kerrouche, 2018, The Journal of dermatological treatment.

N. Kerrouche, A. Bucko, S. Kempers, 2011, The British journal of dermatology.

A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up.

R. Dummer, S. Ibbotson, D. Murrell, 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.